Ontilyv Եվրոպական Միություն - դանիերեն - EMA (European Medicines Agency)

ontilyv

bial portela & companhia s.a. - opicapone - parkinsons sygdom - anti-parkinson-lægemidler - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Madopar "125" 100+25 mg kapsler, hårde Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

madopar "125" 100+25 mg kapsler, hårde

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg

Madopar "125" 100+25 mg tabletter Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

madopar "125" 100+25 mg tabletter

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - tabletter - 100+25 mg

Madopar "62,5" 50 + 12,5 mg kapsler, hårde Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

madopar "62,5" 50 + 12,5 mg kapsler, hårde

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 50 + 12,5 mg

Madopar Depot 100+25 mg depotkapsler, hårde Դանիա - դանիերեն - Lægemiddelstyrelsen (Danish Medicines Agency)

madopar depot 100+25 mg depotkapsler, hårde

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - depotkapsler, hårde - 100+25 mg